Compare McKesson Corporation (MCK) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Unity Software Inc — how do they compare? McKesson Corporation trades at $829.95 (market cap $97.35B), while Unity Software Inc trades at $29.69 (market cap $13.01B). The key difference: McKesson Corporation is far larger — about 7.5× Unity Software Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals.
| MCK | U | |
|---|---|---|
Market Cap | $97.35B | $13.01B |
Sector | Health | Technology |
52-Week High | $995.69 | $49.47 |
52-Week Low | $659.01 | $17.13 |
Enterprise Value | $101.98B | $13.11B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Unity Software (U) trades at $30.14, up 3.97% in the last session, with a bearish technical signal despite recent momentum. Revenue held at $1.85B in 2025, but net losses narrowed to -$403M, improving margins. Analysts are bullish with a $36.50 consensus target, citing AI-driven advertising potential. Cash flow strengthened with $423M from operations in 2025, though high debt and profitability challenges persist.
The stock offers upside if AI initiatives accelerate revenue growth, but risks include sustained losses and competitive pressure. With 69% buy ratings, Wall Street sees value, yet investors must weigh execution risks against the 21% discount to target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
